|
WO2019014201A1
|
|
Extended release molindone compositions
|
|
US2018208599A1
|
|
Polymorphs of ponatinib hydrochloride
|
|
US2019002421A1
|
|
Process and novel polymorphic form of vortioxetine and its pharmaceutically acceptable salts
|
|
US2018127452A1
|
|
Polymorph of regadenoson and process for preparation thereof
|
|
US2018009825A1
|
|
Methods of making eribulin mesylate
|
|
US2018009831A1
|
|
Process for the preparation of novel polymorphic forms of 5-fluoro-1,3-dihydro-1-hydroxy-2,1- benzoxaborole
|
|
US2017260157A1
|
|
Process for preparation and purification of pomalidomide
|
|
US2016362411A1
|
|
Processes for making ponatinib and intermediates thereof
|
|
US2016244474A1
|
|
Process of making regadenoson and novel polymorph thereof
|
|
WO2016069479A1
|
|
Methods of making carfilzomib and intermediates thereof
|
|
WO2015171489A1
|
|
Methods of making netupitant and intermediates thereof
|
